The African Development Bank Group has finalized a $15 million loan to the Biologicals and Vaccines Institute of South Africa Ltd (Biovac) to support the development of a new multi-vaccine manufacturing facility in Cape Town. This investment will dramatically expand Africa’s capacity to produce vaccines domestically. The funding is part of a broader expansion plan that will increase Biovac’s annual production capacity to 500 million doses. When complete, Biovac will become the continent’s first end-to-end...
BREAKING NEWS




















